Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

3.7K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.7K
Erythropoiesis01:14

Erythropoiesis

4.8K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.8K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

2.4K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.4K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

186.9K
Overview
186.9K
Hemoglobin01:24

Hemoglobin

4.6K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
4.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Erythroferrone derived from osteoblasts regulates stress erythropoiesis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).

Kidney international·2026
Same author

Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera.

Leukemia research·2025
Same author

Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis.

Blood·2025
Same author

TNFα signaling restores steady-state hematopoiesis in a TNFαKO mouse model of anemia of inflammation.

Blood·2025

相关实验视频

Updated: Sep 17, 2025

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.8K

铁负荷性贫血症是什么

Maayan V Levy1, Yelena Z Ginzburg2

  • 1The Tisch Cancer Institute, Division of Hematology and Medical Oncology, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Advances in experimental medicine and biology
|July 2, 2025
PubMed
概括
此摘要是机器生成的。

红血细胞的产生,或红细胞生成,是复杂的,由许多因素调节. 对红色素形成的新见解正在改善对铁载体贫血的治疗方法,如β-thalassemia和骨髓发育综合征.

关键词:
红铁 (ERFE) 是一种不有效的红色素质形成.铁过载是因为铁过载.骨髓分裂性综合征 (MDS) 是一种疾病.在 β-thalassemia 的情况下.

更多相关视频

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.2K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.2K

相关实验视频

Last Updated: Sep 17, 2025

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.8K
Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.2K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.2K

科学领域:

  • 血液学 血液学 血液学
  • 分子生物学分子生物学
  • 病理生理学 病理生理学

背景情况:

  • 红细胞形成是骨髓过程中的红细胞 (RBC) 生产,对于氧气运输至关重要.
  • 这个复杂的过程涉及原生细胞的分化,由激素,细胞因子和生长因子调节.
  • 最近的研究已经大大提高了对管理日常红细胞生产的分子机制的理解.

研究的目的:

  • 阐明当前对铁负载性贫血的理解,重点关注β-血病和骨髓质疏松综合征 (MDS).
  • 描述这些失血性发育障碍的尖端病理生理学.
  • 确定目前正在开发的针对这些疾病的新型治疗策略.

主要方法:

  • 审查当前关于红色素形成和铁负载贫血的科学文献.
  • 分析红细胞生产中的分子机制和调节途径.
  • 检查用于新型治疗策略的临床前和临床数据.

主要成果:

  • 增强对红色素质形成的分子协调的理解.
  • 详细了解铁负载性贫血的病理生理学,包括β-thalassemia和MDS.
  • 确定新兴的治疗点和策略,用于dyserythropoietic疾病.

结论:

  • 了解红色素形成的进展对于解决铁载体贫血症至关重要.
  • 针对病理生理学的新型疗法在治疗β-thalassemia和MDS方面表现有前途.
  • 对分子机制的持续研究将推动未来的治疗创新.